GlobeNewswire: Medtronic plc Contains the last 10 of 1112 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T14:35:09ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/08/29/2085765/0/en/Medtronic-Cryoablation-Superior-to-Drug-Therapy-for-Symptomatic-Paroxysmal-Atrial-Fibrillation.html?f=22&fvtc=4&fvtv=29663Medtronic Cryoablation Superior to Drug Therapy for Symptomatic Paroxysmal Atrial Fibrillation2020-08-29T13:00:00Z<![CDATA[ESC Congress: New Research Highlights First-Line Use of Cryoablation as Highly Effective, and with Improved Quality of Life Scores]]>https://www.globenewswire.com/news-release/2020/08/25/2083096/0/en/Medtronic-Reports-First-Quarter-Financial-Results.html?f=22&fvtc=4&fvtv=29663Medtronic Reports First Quarter Financial Results2020-08-25T10:45:00Z<![CDATA[DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020.]]>https://www.globenewswire.com/news-release/2020/08/24/2082468/0/en/Medtronic-Board-Appoints-Kevin-Lofton-as-a-New-Director.html?f=22&fvtc=4&fvtv=29663Medtronic Board Appoints Kevin Lofton as a New Director2020-08-24T11:00:00Z<![CDATA[DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective September 15, 2020. Mr. Lofton will serve on the following committees of the board: Audit, Compensation, and Quality.]]>https://www.globenewswire.com/news-release/2020/08/24/2082452/0/en/Medtronic-Announces-Cash-Dividend-for-Second-Quarter-of-Fiscal-Year-2021.html?f=22&fvtc=4&fvtv=29663Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 20212020-08-24T10:45:00Z<![CDATA[DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) on Friday, August 21, 2020, approved the fiscal year 2021 second quarter cash dividend of $0.58 per ordinary share, representing a 7 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2020. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 43 consecutive years. The dividend is payable on October 16, 2020, to shareholders of record at the close of business on September 25, 2020.]]>https://www.globenewswire.com/news-release/2020/08/21/2082018/0/en/Medtronic-Evolut-TAVR-System-Receives-Updated-U-S-Labeling-Revising-Precaution-for-Treatment-of-Low-Risk-Patients-with-Bicuspid-Aortic-Stenosis.html?f=22&fvtc=4&fvtv=29663Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis 2020-08-21T14:00:00Z<![CDATA[Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR)]]>https://www.globenewswire.com/news-release/2020/08/20/2081457/0/en/Medtronic-Begins-Post-Market-Real-World-Study-of-the-InterStim-Micro-System.html?f=22&fvtc=4&fvtv=29663Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System2020-08-20T14:09:09Z<![CDATA[ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and Non-Obstructive Urinary Retention]]>https://www.globenewswire.com/news-release/2020/08/19/2080961/0/en/Study-Published-in-The-New-England-Journal-of-Medicine-Demonstrates-Patients-Experience-Fewer-Disruptions-to-Dialysis-Therapy-When-Treated-with-Medtronic-Drug-Coated-Balloon.html?f=22&fvtc=4&fvtv=29663Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated with Medtronic Drug-Coated Balloon2020-08-19T21:11:12Z<![CDATA[Results Showed IN. PACT™ AV DCB Is Safe, Reduces Reinterventions, and Helps Maintain Dialysis Access for Those Living with End-Stage Renal Disease]]>https://www.globenewswire.com/news-release/2020/08/11/2076581/0/en/Medtronic-to-Announce-Financial-Results-for-Its-First-Quarter-of-Fiscal-Year-2021.html?f=22&fvtc=4&fvtv=29663Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 20212020-08-11T15:00:00Z<![CDATA[DUBLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2021 on Tuesday, August 25, 2020. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company’s first quarter of fiscal year 2021, which ended on Friday, July 31, 2020.]]>https://www.globenewswire.com/news-release/2020/08/11/2076475/0/en/Medtronic-to-Acquire-Smart-Insulin-Pen-Company-Companion-Medical.html?f=22&fvtc=4&fvtv=29663Medtronic to Acquire Smart Insulin Pen Company Companion Medical2020-08-11T13:00:00Z<![CDATA[Acquisition Expands Medtronic Capabilities to Serve People Using Multiple Daily Injections (MDI) to Manage Diabetes]]>https://www.globenewswire.com/news-release/2020/08/05/2073153/0/en/Medtronic-Announces-Comprehensive-U-S-Launch-of-New-InterStim-Micro-Neurostimulator.html?f=22&fvtc=4&fvtv=29663Medtronic Announces Comprehensive U.S. Launch of New InterStim™ Micro Neurostimulator2020-08-05T11:00:00Z<![CDATA[First Patient Receives New Sacral Neuromodulation Device Implant at Cleveland Clinic]]>